Important information

You are about to view web pages that are not intended for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Hong Kong, Japan, Canada, Singapore, South Africa or New Zealand or any other country where the release, publication or distribution of the information contained in the following web pages is subject to legal restrictions or where the offer or sale of the subscription rights, the interim shares, the interim units, the new shares or the warrants is not permitted.

The information you are seeking to access in the following web pages is being made available by Endomines AB (publ) in good faith and for information purposes only.

By clicking "Yes, I accept" you accept the terms of use below. You must read the following before continuing, and you are requested to read this notice below carefully (it applies to all persons who view these web pages) before reading, accessing or making any other use of the information on the following pages. In accessing the following web pages, you agree to be bound by the following terms and conditions. Please note that the terms set out below may be altered or updated and for that reason you should read them in full each time you visit these web pages.

In certain jurisdictions, the publication or distribution of the information on the following pages may be subject to legal restrictions and all persons accessing these web pages should inform themselves about and abide by such legal restrictions.

The information on the following pages is not directed at or accessible by persons located in the United States, Australia, Hong Kong, Japan, Canada, Singapore, South Africa or New Zealand or in any other country where the offer or sale of the subscription rights, the interim shares, the interim units, the new shares or the warrants is not permitted. In addition, the information on the following pages may not be published or distributed, directly or indirectly, in or into, the United States, Australia, Hong Kong, Japan, Canada, Singapore, South Africa or New Zealand or any other country where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, registration or measures other than those pursuant to Swedish and Finnish law. Nor may the information be forwarded, reproduced or disclosed in such a manner that contravenes such restrictions or would require such additional prospectuses, registration or measures other than those pursuant to Swedish and Finnish law. Failure to comply with these instructions may result in a violation of the United States Securities Act of 1933, as amended ("Securities Act") or laws applicable in other jurisdictions.

No subscription rights, interim shares, interim units, new shares, warrants or other securities issued by Endomines AB (publ) have been or will be registered under the Securities Act, or under any other securities legislation in any state of the United States or any province in Canada. Accordingly, no subscription rights, interim shares, interim units, new shares, warrants or other securities issued by Endomines AB (publ) may be transferred or offered for sale in the United States or Canada, other than in such exceptional cases that do not require registration.

In order to view the information on the following pages, you must certify that you are not located in the United States, Australia, Hong Kong, Japan, Canada, Singapore, South Africa or New Zealand or any other country where such action is wholly or partially subject to legal restrictions and that you have read, understand and agree to comply with all of the restrictions set forth above. You may do so by clicking "Yes, I accept" below. If you are located in the United States, Australia, Hong Kong, Japan, Canada, Singapore, South Africa or New Zealand or any other country imposing such legal restrictions, you must click "No, I do not accept" below.